Cite

HARVARD Citation

    Meng, Q. et al. (2015). Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online]. 
  
Back to record